Sign In
|
|
Free Newsletters
D&B Credit Reports
Businesses for Sale
What's Your Credit Emergency?
Thriving in Tough Times
Trade Magazines
Reduce Health Care Costs
Home
Topics
Bloggers
Franchises
Videos
Podcasts
Library
Ask the Experts
Shop Legal Forms
Find Vendors
Careers
|
Green Business
|
Starting a Business
|
Sales & Selling
|
Business Credit
|
Women in Business
|
Web Tools
|
Company Profiles
Careers
|
Green Business
|
Starting a Business
|
Sales & Selling
|
Business Credit
|
Women in Business
|
Web Tools
|
Company Profiles
Business Travel
|
Manufacturing
|
Retail
|
Sales
|
Starting a Business
|
Technology
|
> See All Topics
|
> See All Industries
Business Intelligence
|
Small Business Blog
|
Finance
|
Operations
|
Sales
|
Technology
|
> See All
AllBusiness AllStars
|
Franchise Directory
|
Buying a Franchise
|
Growing Your Franchise
|
Franchising Your Business
Human Resources
|
Franchises
|
Manufacturing
|
Marketing & Advertising
|
Sales
|
Technology
|
> See All
Finance
|
Green Business
|
Sales
|
Starting a Company
|
Technology
|
Women in Business
|
> See All
Professional Journals
|
Business Answers
|
Company Profiles
|
Glossary
Business Travel
|
Entrepreneurship
|
Finance
|
Franchising
|
Inventing
|
Sales
|
B2B Sales
Form Kits
|
Letter of Intent
|
Web Sites
|
Confidentiality
|
Employment
|
Consulting
|
Due Diligence
|
Demand Letters
|
Business Guides
> See All
Business Directory
|
Quote Center
|
Partner Resources
Enzyme Inhibitors
The best tips and advice from our vast library of articles, videos, and business tools
Browse Related Topics
Pharmaceutical Agents & Products
Pharmaceuticals & Biotechnology
Tools
Businesses for Sale
Business Cash Advance
Business Directory
Lead Lists
Free Magazines
Free Industry Resources
Newly Added Articles
Post Vet Clinic receives prestigious accreditation
Toshiba Releases Portfolio of HD Laptops.
Maysa reflects on weight and image in the music...
Women share dating dos and don'ts
FORT LAUDERDALE ART PIECE DRAWS ATTENTION
ES_B_36_A_01_ANALYSIS.TXT
Britain's Lloyds says HBOS unit makes 10.8 bln...
Search Results
1-20
of 409 related articles
Best Of
Past 30 Days
This Year
Past 5 Years
All Dates
Reports outline HIV/AIDS study results from C.M. Parry et al.
"Mutations can accumulate in the protease and gag genes of human immunodeficiency virus in patients who fail therapy...
unaggregatedarticle
From Touted Vioxx Pain-Killer Drug To PD Rescue, Anti-COX-2 Blocker Salvages Dopamine Brain Neurons.
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research. "Ask your doctor if...
unaggregatedarticle
Other News To Note.
o Ambrilia Biopharma Inc., of Montreal, presented preclinical dataon its series of HIV integrase inhibitors, showing their potential...
unaggregatedarticle
AVILA PRESENTS DATA ON ITS NOVEL, ORALLY-AVAILABLE PROTEASE INHIBITOR, AVL-181, DEMONSTRATING VIRAL CLEARANCE OFHEPATITIS C VIRUS IN PRE-CLINICAL MODELS.
Avila Therapeutics Inc (Avila) presented results of pre-clinical studies on its highly selective, small molecule Hepatitis C Virus...
unaggregatedarticle
Researchers from University of Texas, Health Science Center report details of new studies and findings in the area of chronic myeloid leukemia therapy.
Researchers detail in 'Class effects of tyrosine kinase inhibitorsin the treatment of chronic myeloid leukemia,' new data in...
unaggregatedarticle
Vitae, GSK Enter Collaboration To Develop Renin Inhibitors.
West Coast Editor Talk about making the pulse race: Privately held Vitae Pharmaceuticals Inc., with its renin inhibitor...
unaggregatedarticle
Enanta In-Licenses Chiron's HCV Protease Inhibitor Group.
Staff Writer In the field of hepatitis C virus (HCV) protease inhibitors, Enanta Pharmaceuticals Inc. now has added...
unaggregatedarticle
U.S. Patent Disclosures.
Advanced Tissue Sciences Inc., of La Jolla, Calif., was issued U.S. Patent No. 6,372,494 for the method of...
unaggregatedarticle
Novartis Files For Approval Of Rasilez; Speedel Partner.
Washington Editor A drug developed in part by the Speedel Group, SPP100 (aliskiren),now is under FDA review after...
unaggregatedarticle
Concurrent Pharma Takes Over Allergan's Retinoids For Equity.
National Editor Acquiring the same development team that discovered the topical tazarotene known as Tazorac - though not...
unaggregatedarticle
Scientists at University of Texas target enzyme research.
"Molecules that block nitric oxide's (NO) biosynthesis are of significant interest. For example, nitric oxide synthase (NOS) inhibitorshave...
unaggregatedarticle
HIGH BLOOD PRESSURE MEDICINES SHOW PROMISE FOR TREATING HEART DISEASE
The following information was released by the Agency for Healthcare Research and Quality (AHRQ): Two medications commonly used...
unaggregatedarticle
NewCo News: Viamet Gets $4 Million Series A For Targeting Metalloenzymes.
Staff Writer Viamet Pharmaceuticals Inc. raised $4 million in a Series A financing to support its preclinical development...
unaggregatedarticle
Isis Presents Interim ISIS 2503 Phase II Pancreatic Cancer Data.
Senior Staff Writer Isis Pharmaceuticals Inc. presented positive data from a planned interim analysis of a pancreatic cancer...
unaggregatedarticle
Pharmion, MethylGene Team For $100M Cancer Partnership.
Washington Editor In a new joint research venture worth up to $100 million, MethylGene Inc. and Pharmion are...
unaggregatedarticle
Data on HIV/AIDS discussed by S. Banke and colleagues.
According to recent research published in the Journal of Virology,"Human immunodeficiency virus type 1 (HIV-1) protease inhibitors (PIs)...
unaggregatedarticle
Astex, AstraZeneca Shape Potential $275M Agreement.
BioWorld International Correspondent LONDON - Astex Therapeutics Ltd. agreed to a deal with AstraZenecaplc for a range of...
unaggregatedarticle
Research reports on enzyme research from J.R. Simard and colleagues provide new insights.
According to recent research from Dortmund, Germany, "Kinase disregulation disrupts the intricate network of intracellular signaling pathways and...
unaggregatedarticle
Reports from University of California describe recent advances in drug development
According to a study from the United States, "The recent withdrawal of Cox-2 Inhibitors has generated debate on...
unaggregatedarticle
Other News To Note.
o BioTime Inc., of Berkeley, Calif., reported the results of its studies in which rats survived the loss...
unaggregatedarticle
1-20
of 409 related articles
1
2
3
4
5
6
7
8
9
10
Next
Press Releases
NitroMed Special Meeting of Stockholders Further...
NitroMed Receives Revised Unsolicited Acquisition...
NitroMed Special Meeting of Stockholders Adjourned...
Are You Ready to Start Your Dream Business?
Sumer Morenz of D&B Digital TV hits the streets of San Francisco to ask people about the businesses they want to start.
Franchise Finder
Find your perfect franchise
Choose your location and industry and we'll show you the most relevant franchises.
Industry:
All Industries
Automotive Franchises
Business-to-Business Franchises
Children's Franchises
General Service Franchises
Health and Wellness Franchises
Home Service Franchises
Personal Care Franchises
Personal Finance Franchises
Pet Franchises
Restaurant and Food Franchises
Retail Franchises
Travel and Leisure Franchises
Location:
All Locations
United States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Worldwide
Africa
Asia
Australia/New Zealand
Canada
Central America
Europe
Mexico
Middle East
South America
Premium Content
Inhibitors of cyclin-dependent kinases as...
Fermentation microbiology and biotechnology, 2d ed.
Advanced materials.(Highlights)